The analyses demonstrate that all the complexes examined were stable in both cell-free environments and inside lung cancer cells. They were not reduced and did not release their ligands to form new ...

Lung cancer remains one of the deadliest cancers globally. Non-small cell lung cancer (NSCLC), which accounts for 85% of all lung cancer cases, is particularly challenging to treat due to ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease ... a plasma cell cancer, could potentially be repurposed to treat IPF.